Linked Life Data

1289537

Source:http://linkedlifedata.com/resource/pubmed/id/1289537

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1993-3-19
pubmed:abstractText
The edentulous posterior maxilla often has inadequate bone for endosteal implants. Therefore, implant placement in this area often requires the manipulation of maxillary sinus anatomy. The development of infection following sinus elevation procedures can occur from contamination of the site by oral and/or sinus pathogens or secondary infection from a maxillary sinusitis. The prevention and prompt treatment of complications associated with this surgery can contribute to increased success in this area. The prophylactic use of systemic and local antibiotics and glucocorticosteroids can reduce the risk of infection. If infection develops, culture and sensitivity testing is indicated, with the prescription of empiric antibiotic therapy and decongestants. A knowledge of clinical pharmacology and its therapeutic application is essential for the predictable management of sinus elevation surgery.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0160-6972
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
15-23
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
The pharmacologic management of maxillary sinus elevation surgery.
pubmed:affiliation
Oral Implantology Center, University of Pittsburgh, School of Dental Medicine, PA 15261.
pubmed:publicationType
Journal Article